COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1776: Articles 17751-17760  | Next

An exploratory study on the correlation of population SARS-CoV-2 cycle threshold values to local disease dynamics
Tso, C. F., Garikipati, A., Green-Saxena, A., Mao, Q., Das, R.
10.1101/2021.02.16.21251844 — Posted: 2021-02-19
Healthcare-associated COVID-19 in England: a national data linkage study
Bhattacharya, A., Collin, S. M., Stimson, J., Thelwall, S., Nsonwu, O., Gerver, S., Robotham, J., Wilcox, M., Hopkins, S., Hope, R.
10.1101/2021.02.16.21251625 — Posted: 2021-02-19
SARS-CoV-2 seropositivity after infection and antibody response to mRNA-based vaccination
Ciccone, E. J., Zhu, D. R., Ajeen, R., Shook-Sa, B. E., Boyce, R. M., COVID HCW Study Team, , Aiello, A. E.
10.1101/2021.02.09.21251319 — Posted: 2021-02-19
Predictive Modeling of COVID-19 Case Growth Highlights Evolving Demographic Risk Factors in Tennessee and Georgia
Gray, J. D., Harris, C. R., Wylezinski, L. S., Spurlock, C. F.
10.1101/2021.02.09.21251106 — Posted: 2021-02-19
Evaluating social and spatial inequalities of large scale rapid lateral flow SARS-CoV-2 antigen testing in COVID-19 management: An observational study of Liverpool, UK (November 2020 to January 2021)
Green, M. A., Garcia-Finana, M., Barr, B., Burnside, G., Cheyne, C., Hughes, D., Ashton, M., Sheard, S., Buchan, I.
10.1101/2021.02.10.21251256 — Posted: 2021-02-19
A comparison of performance metrics for cloth face masks as source control devices for simulated cough and exhalation aerosols
Lindsley, W. G., Blachere, F. M., Beezhold, D. H., Law, B. F., Derk, R. C., Hettick, J. M., Woodfork, K., Goldsmith, W. T., Harris, J. R., Duling, M. G., Boutin, B., Nurkiewicz, T., Noti, J. D.
10.1101/2021.02.16.21251850 — Posted: 2021-02-19
Lockdown and non-COVID-19 deaths: Cause-specific mortality during the first wave of the 2020 pandemic in Norway. A population-based register study
Raknes, G., Strom, M. S., Sulo, G., Overland, S. N., Roelants, M., Juliusson, P. B.
10.1101/2021.02.09.21251326 — Posted: 2021-02-19
Increased hazard of mortality in cases compatible with SARS-CoV-2 variant of concern 202012/1 - a matched cohort study
Challen, R., Brooks-Pollock, E., Read, J. M., Dyson, L., Tsaneva-Atanasova, K., Danon, L.
10.1101/2021.02.09.21250937 — Posted: 2021-02-19
Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual
Yan, B., Chakravorty, S., Mirabelli, C., Wang, L., Trujillo-Ochoa, J. L., Chauss, D., Kumar, D., Lionakis, M. S., Olson, M. R., Wobus, C. E., Afzali, B., Kazemian, M.
10.1101/2021.02.17.431704 — Posted: 2021-02-19
Sensitivity of the Elecsys Anti-SARS-CoV-2 immunoassay as an aid in determining previous exposure to SARS-CoV-2
Hegel, J. K., Riester, E., Rank, C. M., Langen, F., Laengin, T., Findeisen, P.
10.1101/2021.02.11.21250290 — Posted: 2021-02-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).